Healthcare operations

HUTCHMED’s ATLED® (Fanregratinib) gains approval from China’s NMPA for intrahepatic cholangiocarcinoma treatment, marking a key regulatory milestone.

• leftbrainmarketing Team
• 28. August 2026

The FDA has approved a new targeted treatment for metastatic pancreatic cancer, marking a significant step in patient safety and medical innovation.

• Thorsten Meyer
• 27. August 2026

Exploring how consumer health and safety monitoring is shifting towards neurological developments, with potential industry impacts and ongoing uncertainties.

• Thorsten Meyer
• 26. August 2026

A new phone-camera shade scoring app aims to objectively measure teeth whitening progress, transforming home dental care with innovative technology.

• Thorsten Meyer
• 25. August 2026

Rznomics has joined Lilly Gateway Labs in San Diego to accelerate development of RNA-based therapeutics, marking a strategic collaboration in biotech innovation.

• leftbrainmarketing Team
• 24. August 2026

A pilot study tests daily gum-line photo scoring via smartphones to detect early inflammation, aiming to improve at-home oral health monitoring.

• Thorsten Meyer
• 11. August 2026

ArcherFRS partners with Hillsborough County Fire Rescue and Tampa General Hospital to pilot the first EMS-led drone delivery of whole blood, enhancing emergency medical response.

• leftbrainmarketing Team
• 8. August 2026

LeMaitre will participate in the 11th Annual Needham Virtual MedTech & Diagnostics 1×1 Conference, scheduled for this month, highlighting its latest developments.

• leftbrainmarketing Team
• 7. August 2026

New operations software for hospital chaplaincy teams is being tested to improve scheduling, documentation, and accreditation readiness, promising a major workflow upgrade.

• Thorsten Meyer
• 6. August 2026

New CRISPR technology can selectively target and destroy cancer cells, including ‘undruggable’ types, promising advances in consumer safety and treatment.

• Thorsten Meyer
• 24. July 2026